跳至主要内容
临床试验/NCT06474819
NCT06474819招募中不适用

Left Septal or Deep Septal Pacing to Prevent Pacing-induced Cardiomyopathy

Institut d'Investigació Biomèdica de Bellvitge8 个研究点 分布在 1 个国家目标入组 326 人开始时间: 2024年7月12日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
326
试验地点
8
主要终点
Pacing-induced cardiomyopathy

研究概览

简要总结

Multicenter randomized controlled trial which will include patients with left ventricular ejection fraction >50% requiring a first implant of a cardiac pacemaker with expected high pacing percentages.

Patients will be randomized 1:1 to right ventricular apical pacing vs left septal or deep septal pacing. The primary endpoint will be pacing-induced cardiomyopathy during the first year of follow-up.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First implant of a single-chamber or dual chamber pacemaker due to persistent bradycardia associated with high degree atrio-ventricular (AV) block (complete AV block or second degree type II AV block), with second-degree type I AV block (symptomatic or associated with intra-hisian or infra-hisian block), or with atrial fibrillation with symptomatic slow ventricular rate (<45lpm).
  • LVEF>50% at echocardiography performed maximum 7 days before pacemaker implant.
  • Informed consent signature.

排除标准

  • Life expectancy <12 months
  • Severe cardiac valvular abnormality requiring intervention
  • Unstable Angina, Acute myocardial infarction, coronary revascularization, valvular surgery or valvular percutaneous intervention in the 90 days prior to pacemaker implant.
  • Inclusion in another trial which may influence the results of this study.

结局指标

主要结局

Pacing-induced cardiomyopathy

时间窗: 12 months

Decrease in the left ventricular ejection fraction (LVEF) by \>10% as compared to the LVEF before pacemaker implant and final LVEF\<45%.

次要结局

  • heart failure(12 months)
  • LVEF during follow-up(12 months)
  • Mitral and tricuspid regurgitation(12 months)
  • Brain Natriuretic Peptide levels(12 months)
  • New York Heart Association (NYHA) class(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Di Marco

Principal Investigator

Institut d'Investigació Biomèdica de Bellvitge

研究点 (8)

Loading locations...

相似试验

Left Septal or Deep Septal Pacing to Prevent... | 临床试验